Technomark is an investment group with a life science focus.
Since 1987, Technomark has had an impeccable reputation in the life science industry for strategic planning, venture capital, and product development.
Today, our global presence allows us to make a difference by providing turn-key solutions for clinical development programs primarily in the in the US and Europe, and other selective regions, as part of our co-development investment business model.
As long-term investors we invest and co-fund the clinical development of our portfolio companies in a hands-on manner. |
|
| |
| Investment Summary |
| Industry sector: |
|
Therapeutics (biologics, NCE, orphan), med-tech, device/diagnostic |
| Size of investment: |
|
Seed to Series C |
| Investment stage: |
|
Phase I-IV clinical trial |
| Return on investment: |
|
Equity, downstream royalties, milestone payments, etc. |
| Geography: |
|
UK and rest of EU, US, Israel, etc. |
|
